Page 1903 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 109 Complications After Hematopoietic Cell Transplantation 1684.e1

REFERENCES 22. McCurdy SR, Kanakry JA, Showel MM, et al: Risk-stratified outcomes
of nonmyeloablative, HLA-haploidentical BMT with high-dose post-
1. Tomblyn M, Chiller T, Einsele H, et al: Guidelines for preventing infec- transplantation cyclophosphamide. Blood 2015.
tious complications among hematopoietic cell transplantation recipients: 23. Ciurea SO, Thall PF, Wang X, et al: Donor-specific anti-HLA Abs
a global perspective. Biol Blood Marrow Transplant 15:1143, 2009. and graft failure in matched unrelated donor hematopoietic stem cell
2. van Burik JA, Brunstein CG: Infectious complications following unre- transplantation. Blood 118(22):5957–5964, 2011.
lated cord blood transplantation. Vox Sang 92(4):289–296, 2007. 24. Arfons LM, Tomblyn M, Rocha V, et al: Second hematopoietic stem
3. van Burik JA, Weisdorf DJ: Infections in recipients of blood and marrow cell transplantation in myeloid malignancies. Curr Opin Hematol
transplantation. Hematol Oncol Clin North Am 13(5):1065–1089, 1999, 16(2):112–123, 2009.
viii. 25. McDonald GB: Hepatobiliary complications of hematopoietic cell
4. Rizzo JD, Wingard JR, Tichelli A, et al: Recommended screening and transplantation, 40 years on. Hepatology 51(4):1450–1460, 2010.
preventive practices for long-term survivors after hematopoietic cell 26. Ho VT, Revta C, Richardson PG: Hepatic veno-occlusive disease
transplantation: joint recommendations of the European Group for after hematopoietic stem cell transplantation: update on defibrotide
Blood and Marrow Transplantation, the Center for International Blood and other current investigational therapies. Bone Marrow Transplant
and Marrow Transplant Research, and the American Society of Blood and 41(3):229–237, 2008.
Marrow Transplantation. Biol Blood Marrow Transplant 12(2):138–151, 27. Panoskaltsis-Mortari A, Griese M, Madtes DK, et al: An official
2006. American Thoracic Society research statement: noninfectious lung injury
5. Freifeld AG, Bow EJ, Sepkowitz KA, et al: Clinical practice guideline after hematopoietic stem cell transplantation: idiopathic pneumonia
for the use of antimicrobial agents in neutropenic patients with cancer: syndrome. Am J Respir Crit Care Med 183(9):1262–1279, 2011.
2010 Update by the Infectious Diseases Society of America. Clin Infect 28. Yanik GA, Horowitz MM, Weisdorf DJ, et al: Randomized, double-blind,
Dis 52(4):427–431, 2011. placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel
6. Corey L, Boeckh M: Persistent fever in patients with neutropenia. N Engl (etanercept) for the treatment of idiopathic pneumonia syndrome after
J Med 346(4):222–224, 2002. allogeneic stem cell transplantation: blood and marrow transplant clinical
7. Boeckh M, Ljungman P: How we treat cytomegalovirus in hematopoietic trials network protocol. Biol Blood Marrow Transplant 20(6):858–864,
cell transplant recipients. Blood 113(23):5711–5719, 2009. 2014.
8. Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord 29. Yanik GA, Ho VT, Levine JE, et al: The impact of soluble tumor necrosis
Blood Transplant for Hematologic Malignancy. http://clinicaltrials.gov/ct2/ factor receptor etanercept on the treatment of idiopathic pneumonia
show/NCT00891137 Accessed December 15, 2014. syndrome after allogeneic hematopoietic stem cell transplantation. Blood
9. Foley B, Cooley S, Verneris MR, et al: Cytomegalovirus reactivation 112(8):3073–3081, 2008.
after allogeneic transplantation promotes a lasting increase in educated 30. Majhail NS, Parks K, Defor TE, et al: Diffuse alveolar hemorrhage and
NKG2C+ natural killer cells with potent function. Blood 119(11):2665– infection-associated alveolar hemorrhage following hematopoietic stem
2674, 2012. cell transplantation: related and high-risk clinical syndromes. Biol Blood
10. Razonable RR, Humar A: Practice ASTIDCo. Cytomegalovirus in solid Marrow Transplant 12(10):1038–1046, 2006.
organ transplantation. Am J Transplant 13(Suppl 4):93–106, 2013. 31. Majhail NS, Parks K, Defor TE, et al: Alveolar hemorrhage following
11. Betts BC, Young JA, Ustun C, et al: Human herpesvirus 6 infection after allogeneic hematopoietic cell transplantation using reduced-intensity
hematopoietic cell transplantation: is routine surveillance necessary? Biol conditioning. Bone Marrow Transplant 38(11):765–768, 2006.
Blood Marrow Transplant 17(10):1562–1568, 2011. 32. Wingard JR, Majhail NS, Brazauskas R, et al: Long-term survival and
12. A phase II, randomized, double-blind, placebo-controlled study to examine late deaths after allogeneic hematopoietic cell transplantation. J Clin
the effects of DAS181 in immunocompromised subjects with lower respira- Oncol 29(16):2230–2239, 2011.
tory tract parainfluenza infection on supplemental oxygen (DAS181-2- 33. Gooley TA, Chien JW, Pergam SA, et al: Reduced mortality after allogeneic
05). http://www.clinicaltrials.gov/ct2/show/NCT01644877 Accessed hematopoietic-cell transplantation. N Engl J Med 363(22):2091–2101,
December 15, 2014. 2010.
13. Wingard JR: The changing face of invasive fungal infections in hemato- 34. Sun CL, Francisco L, Kawashima T, et al: Prevalence and predictors
poietic cell transplant recipients. Curr Opin Oncol 17(2):89–92, 2005. of chronic health conditions after hematopoietic cell transplantation:
14. Marr KA, Seidel K, Slavin MA, et al: Prolonged fluconazole prophylaxis a report from the Bone Marrow Transplant Survivor Study. Blood
is associated with persistent protection against candidiasis-related death 116(17):3129–3139, 2010; quiz 377.
in allogeneic marrow transplant recipients: long-term follow-up of a 35. Majhail NS, Rizzo JD, Lee SJ, et al: Recommended screening and
randomized, placebo-controlled trial. Blood 96(6):2055–2061, 2000. preventive practices for long-term survivors after hematopoietic cell
15. Pappas PG, Kauffman CA, Andes D, et al: Clinical practice guidelines transplantation. Bone Marrow Transplant 47(3):337–341, 2012.
for the management of candidiasis: 2009 update by the Infectious 36. Majhail NS: Secondary cancers following allogeneic haematopoietic cell
Diseases Society of America. Clin Infect Dis 48(5):503–535, 2009. transplantation in adults. Br J Haematol 154(3):301–310, 2011.
16. Upton A, Kirby KA, Carpenter P, et al: Invasive aspergillosis following 37. Rizzo JD, Curtis RE, Socie G, et al: Solid cancers after allogeneic
hematopoietic cell transplantation: outcomes and prognostic factors hematopoietic cell transplantation. Blood 113(5):1175–1183, 2009.
associated with mortality. Clin Infect Dis 44(4):531–540, 2007. 38. Armenian SH, Sun CL, Kawashima T, et al: Long-term health-related
17. Wingard JR, Carter SL, Walsh TJ, et al: Randomized, double-blind outcomes in survivors of childhood cancer treated with HSCT versus
trial of fluconazole versus voriconazole for prevention of invasive fungal conventional therapy: a report from the Bone Marrow Transplant Sur-
infection after allogeneic hematopoietic cell transplantation. Blood vivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS).
116(24):5111–5118, 2010. Blood 118(5):1413–1420, 2011.
18. Walsh TJ, Anaissie EJ, Denning DW, et al: Treatment of aspergillosis: 39. Sun CL, Francisco L, Baker KS, et al: Adverse psychological outcomes
clinical practice guidelines of the Infectious Diseases Society of America. in long-term survivors of hematopoietic cell transplantation: a report
Clin Infect Dis 46(3):327–360, 2008. from the Bone Marrow Transplant Survivor Study (BMTSS). Blood
19. Jahagirdar BN, Morrison VA: Emerging fungal pathogens in patients 118(17):4723–4731, 2011.
with hematologic malignancies and marrow/stem-cell transplant recipi- 40. Scherwath A, Schirmer L, Kruse M, et al: Cognitive functioning in
ents. Semin Respir Infect 17(2):113–120, 2002. allogeneic hematopoietic stem cell transplantation recipients and its
20. Seidel MG, Peters C, Wacker A, et al: Randomized phase III study of medical correlates: a prospective multicenter study. Psychooncology
granulocyte transfusions in neutropenic patients. Bone Marrow Trans- 22(7):1509–1516, 2013.
plant 42(10):679–684, 2008. 41. Jagasia MH, Greinix HT, Arora M, et al: National Institutes of Health
21. Ang AL, Linn YC: Treatment of severe neutropenic sepsis with granulo- Consensus Development Project on Criteria for Clinical Trials in Chronic
cyte transfusion in the current era–experience from an adult haematology Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working
unit in Singapore. Transfus Med 21(1):13–24, 2011. Group report. Biol Blood Marrow Transplant 21(3):389–401.e1, 2015.